Tc-99m PMT whole-body scintigraphy for evaluation of therapeutic effect and for monitoring bone metastasis in a patient with hepatocellular carcinoma

被引:5
|
作者
Sueyoshi, K [1 ]
Narabayashi, I [1 ]
Doi, K [1 ]
Takahashi, M [1 ]
Komori, T [1 ]
Tatsu, Y [1 ]
Tatsumi, T [1 ]
Utunomiya, K [1 ]
Uesugi, Y [1 ]
Adachi, I [1 ]
Shimizu, T [1 ]
机构
[1] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan
关键词
bone metastases; bone scintigraphy; hepatocellular carcinoma; Tc-99m PMT whole-body scintigraphy;
D O I
10.1097/00003072-200012000-00008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Detection of metastatic lesions by bone scintigraphy is highly sensitive but has a low rate of specificity. Often bone metastases from hepatocellular carcinoma are not detected by bone scintigraphy because of low uptake or a photopenic area in the tumor. In contrast, Tc-99m Sn-N-pyridoxy-5-methyltryptophan (Tc-99m PMT) whole-body scintigraphy reflects tumor viability, and the specificity of detection is so high that tumor structure can be shown well. Tc-99m PMT whole-body scintigraphy was helpful for evaluating the response to therapy and monitoring the course of the patient described here with bone metastasis from hepatocellular carcinoma.
引用
收藏
页码:1000 / 1003
页数:4
相关论文
共 50 条
  • [1] METASTASIS OF HEPATOCELLULAR-CARCINOMA TO THE COLON DEMONSTRATED BY TC-99M PMT SCINTIGRAPHY
    FUKUI, H
    KASHIWAGI, T
    SHIRAI, Y
    MATSUDA, Y
    KAWATA, S
    NISHIMURA, T
    KOZUKA, T
    CLINICAL NUCLEAR MEDICINE, 1993, 18 (06) : 512 - 515
  • [2] Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastases from hepatocellular carcinoma
    Sueyoshi, K
    Narabayashi, I
    Aratani, T
    Doi, K
    Komori, T
    Ogura, Y
    Utsunomiya, K
    Shimidzu, T
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (03) : 221 - 224
  • [3] Lutein cyst inadvertently detected on Tc-99m MDP whole-body bone scintigraphy
    Kida, T
    Takahashi, S
    CLINICAL NUCLEAR MEDICINE, 1998, 23 (01) : 52 - 53
  • [4] Tc-99m PMT hepatobiliary scintigraphy in the differential diagnosis of extrahepatic metastases and hepatocellular carcinoma
    Mochizuki, T
    Tsuda, T
    Sugawara, Y
    Tanaka, H
    Kikuchi, T
    Miyagawa, M
    Shimizu, K
    Murase, K
    Iuchi, H
    Onji, M
    Ikezoe, J
    CLINICAL NUCLEAR MEDICINE, 2000, 25 (12) : 991 - 995
  • [5] Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma
    Almeida, P
    Ravizzini, GC
    Almeida, C
    Borges-Neto, S
    CLINICAL NUCLEAR MEDICINE, 2000, 25 (06) : 443 - 446
  • [6] Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions
    Yoshio Tanabe
    Masayuki Hashimoto
    Yasufumi Ohuchi
    Fumiko Kodama
    Toshihide Ogawa
    Annals of Nuclear Medicine, 2000, 14 : 485 - 488
  • [7] Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions
    Tanabe, Y
    Hashimoto, M
    Ohuchi, Y
    Kodama, F
    Ogawa, T
    ANNALS OF NUCLEAR MEDICINE, 2000, 14 (06) : 485 - 488
  • [8] Tc-99m methoxyisobutylisonitrile parathyroid scintigraphy: the value of adding a whole-body scan
    Tiktinsky, Ekaterina
    Horne, Tifha
    Agranovich, Svetlana
    Lantsberg, Sophie
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (11) : 1079 - 1083
  • [9] Extraosseous metastases of hepatocellular carcinoma detection and therapeutic assessment with Tc-99m PMT SPECT
    Hayase, N
    Fukumoto, M
    Yoshida, D
    Kariya, S
    Akagi, N
    Kurohara, A
    Hisa, N
    Yoshida, S
    CLINICAL NUCLEAR MEDICINE, 1999, 24 (05) : 326 - 329
  • [10] Tc-99m MDP scintigraphy of temporal bone metastasis from breast carcinoma
    Nguyen, BD
    Chin, BB
    Regan, F
    Bohlman, ME
    CLINICAL NUCLEAR MEDICINE, 1998, 23 (04) : 253 - 254